4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-018740
Senior Vice President and CFO sold 11,750 shares at an average $7.81 ($91,710)
- Senior Vice President and CFO acquired 9,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-14 | Exercise or conversion : show line 1 in the form | +4,500 | $1.42 | $6,390 | 137,176 | D |
| 2019-05-14 | Sale : show line 2 in the form | −4,500 | $7.62 | $34,290 | 132,676 | D |
| 2019-05-15 | Exercise or conversion : show line 3 in the form | +4,750 | $1.42 | $6,745 | 137,426 | D |
| 2019-05-15 | Sale : show line 4 in the form | −7,250 | $7.92 | $57,420 | 130,176 | D |
| Open-market sales · 11,750 sh · avg $7.81 · $91,710 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-05-14 | Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) | −4,500 | 70,500 | D |
| 2019-05-15 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −4,750 | 65,750 | D |
Loading xslF345X03/form4.xml…